United Therapeutics (UTHR) News Today $316.34 -4.03 (-1.26%) Closing price 05/30/2025 04:00 PM EasternExtended Trading$316.78 +0.44 (+0.14%) As of 05/30/2025 06:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock UTHR Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period 13,541 Shares in United Therapeutics Co. (NASDAQ:UTHR) Purchased by Lansforsakringar Fondforvaltning AB publLansforsakringar Fondforvaltning AB publ acquired a new position in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 13,541 shares ofMay 30 at 5:32 AM | marketbeat.comPublic Employees Retirement System of Ohio Sells 1,090 Shares of United Therapeutics Co. (NASDAQ:UTHR)Public Employees Retirement System of Ohio trimmed its position in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 6.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 16,291 shares of the biotechnoloMay 30 at 4:22 AM | marketbeat.comUnited Therapeutics Co. (NASDAQ:UTHR) Given Consensus Rating of "Moderate Buy" by BrokeragesShares of United Therapeutics Co. (NASDAQ:UTHR - Get Free Report) have been given an average rating of "Moderate Buy" by the twelve analysts that are presently covering the firm, MarketBeat.com reports. Four analysts have rated the stock with a hold rating and eight have assigned a buy rating toMay 30 at 3:06 AM | marketbeat.comUnited Therapeutics Co. (NASDAQ:UTHR) Shares Purchased by Voloridge Investment Management LLCVoloridge Investment Management LLC increased its position in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 47.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 6,864 shares of tMay 29 at 4:29 AM | marketbeat.comPolar Asset Management Partners Inc. Takes $7.80 Million Position in United Therapeutics Co. (NASDAQ:UTHR)Polar Asset Management Partners Inc. purchased a new position in United Therapeutics Co. (NASDAQ:UTHR - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 22,100 shares of tMay 28 at 5:51 AM | marketbeat.comLiquidia Scores FDA Nod For Lung Disease Drug Yutrepia, Faces Legal ChallengeMay 27, 2025 | benzinga.comGF Fund Management CO. LTD. Makes New Investment in United Therapeutics Co. (NASDAQ:UTHR)GF Fund Management CO. LTD. bought a new stake in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) in the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 937 shares of the biotechnology company's stock, valued at approximately $331,000.May 27, 2025 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Increases Position in United Therapeutics Co. (NASDAQ:UTHR)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 9.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 232May 27, 2025 | marketbeat.comTwo Sigma Advisers LP Has $4.16 Million Stock Position in United Therapeutics Co. (NASDAQ:UTHR)Two Sigma Advisers LP lowered its holdings in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 9.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 11,800 shares of the biotechnology company's stock afterMay 27, 2025 | marketbeat.comLiquidia Retail Buzz Surges After BofA Raises Price Target to $25 On Yutrepia FDA NodMay 27, 2025 | msn.comQuantinno Capital Management LP Buys 1,003 Shares of United Therapeutics Co. (NASDAQ:UTHR)Quantinno Capital Management LP lifted its stake in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 76.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,311 shares of the biotechnology company's stock afterMay 26, 2025 | marketbeat.comQ2 EPS Forecast for United Therapeutics Reduced by AnalystUnited Therapeutics Co. (NASDAQ:UTHR - Free Report) - Equities research analysts at Zacks Research cut their Q2 2025 EPS estimates for United Therapeutics in a note issued to investors on Tuesday, May 20th. Zacks Research analyst R. Department now anticipates that the biotechnology company will pMay 25, 2025 | marketbeat.comQ3 EPS Estimate for United Therapeutics Reduced by AnalystUnited Therapeutics Co. (NASDAQ:UTHR - Free Report) - Equities research analysts at Zacks Research decreased their Q3 2025 EPS estimates for shares of United Therapeutics in a research note issued on Tuesday, May 20th. Zacks Research analyst R. Department now expects that the biotechnology companMay 24, 2025 | marketbeat.comTidal Investments LLC Sells 1,567 Shares of United Therapeutics Co. (NASDAQ:UTHR)Tidal Investments LLC decreased its holdings in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 13.9% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 9,705 shares of the biotechnology company's stock after selling 1,567 shares during the perMay 24, 2025 | marketbeat.comProShare Advisors LLC Trims Stock Holdings in United Therapeutics Co. (NASDAQ:UTHR)ProShare Advisors LLC cut its holdings in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 54.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,203 shares of the biotechnology compaMay 24, 2025 | marketbeat.comMIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Purchases 1,342 Shares of United Therapeutics Co. (NASDAQ:UTHR)MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 26.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 6,446 shares of the biotechnology coMay 24, 2025 | marketbeat.comZacks Research Analysts Reduce Earnings Estimates for UTHRMay 24, 2025 | americanbankingnews.comZacks Research Has Pessimistic Outlook of UTHR Q2 EarningsMay 24, 2025 | americanbankingnews.comLiquidia's Yutrepia gets FDA approval for added indicationMay 23, 2025 | msn.comMidWestOne Financial Group Inc. Increases Stock Holdings in United Therapeutics Co. (NASDAQ:UTHR)MidWestOne Financial Group Inc. raised its stake in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 23.2% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 6,847 shares of the biotechnology company's stock after buying anMay 23, 2025 | marketbeat.comUnited Therapeutics Co. (NASDAQ:UTHR) Shares Bought by Vident Advisory LLCVident Advisory LLC raised its holdings in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 15.0% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 12,221 shares of the biotechnology cMay 23, 2025 | marketbeat.comKrensavage Asset Management LLC Has $53 Million Stock Holdings in United Therapeutics Co. (NASDAQ:UTHR)Krensavage Asset Management LLC increased its stake in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 49.7% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 150,205 shares of the biotechnology company's stock after buyMay 22, 2025 | marketbeat.comFocus Partners Wealth Boosts Position in United Therapeutics Co. (NASDAQ:UTHR)Focus Partners Wealth grew its holdings in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 127.1% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,917 shares of the biotechnology company's stock after purchasing an aMay 22, 2025 | marketbeat.comUnited Therapeutics Co. (NASDAQ:UTHR) Stake Increased by Soleus Capital Management L.P.Soleus Capital Management L.P. boosted its stake in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 7.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 109,394 shares of the biotechnoloMay 21, 2025 | marketbeat.comSummit Street Capital Management LLC Cuts Stock Holdings in United Therapeutics Co. (NASDAQ:UTHR)Summit Street Capital Management LLC lowered its position in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 10.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 32,443 shares of the biotechnology company'sMay 20, 2025 | marketbeat.comRaiffeisen Bank International AG Acquires New Position in United Therapeutics Co. (NASDAQ:UTHR)Raiffeisen Bank International AG bought a new position in United Therapeutics Co. (NASDAQ:UTHR - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 1,712 shares of the biotechnology company's stock, valued at approximately $612,0May 20, 2025 | marketbeat.comRafferty Asset Management LLC Has $13.44 Million Stock Position in United Therapeutics Co. (NASDAQ:UTHR)Rafferty Asset Management LLC lessened its holdings in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 25.3% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 38,084 sharesMay 19, 2025 | marketbeat.comNomura Holdings Inc. Takes Position in United Therapeutics Co. (NASDAQ:UTHR)Nomura Holdings Inc. acquired a new stake in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 5,924 shares of the biotechnology company's stock, valued at appMay 19, 2025 | marketbeat.comNuveen Asset Management LLC Cuts Stake in United Therapeutics Co. (NASDAQ:UTHR)Nuveen Asset Management LLC lowered its position in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 7.8% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 331,675 shares of the biotechnology company's stock aftMay 19, 2025 | marketbeat.comPolar Asset Management Partners Inc. Invests $7.80 Million in United Therapeutics Co. (NASDAQ:UTHR)Polar Asset Management Partners Inc. acquired a new position in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 22,100 shares ofMay 18, 2025 | marketbeat.comOMERS ADMINISTRATION Corp Has $2.58 Million Stock Position in United Therapeutics Co. (NASDAQ:UTHR)OMERS ADMINISTRATION Corp reduced its position in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 34.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 7,310 shares of the biotechnology company's stoMay 17, 2025 | marketbeat.comLazard Asset Management LLC Sells 4,795 Shares of United Therapeutics Co. (NASDAQ:UTHR)Lazard Asset Management LLC decreased its holdings in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 15.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 25,477 sharesMay 17, 2025 | marketbeat.comInteresting UTHR Put And Call Options For July 18thMay 16, 2025 | nasdaq.comMPM Bioimpact LLC Makes New $8.12 Million Investment in United Therapeutics Co. (NASDAQ:UTHR)MPM Bioimpact LLC acquired a new stake in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 23,000 shares of the biotechnology company's stoMay 16, 2025 | marketbeat.comParkman Healthcare Partners LLC Cuts Stock Holdings in United Therapeutics Co. (NASDAQ:UTHR)Parkman Healthcare Partners LLC reduced its stake in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 41.5% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 37,472 shares of the biotechnology company's stock aftMay 16, 2025 | marketbeat.comEthic Inc. Makes New $959,000 Investment in United Therapeutics Co. (NASDAQ:UTHR)Ethic Inc. bought a new position in United Therapeutics Co. (NASDAQ:UTHR - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 2,718 shares of the biotechnology company's stock, valued at approximately $959May 16, 2025 | marketbeat.comUTHR Q1 Earnings Call: Double-Digit Growth Continues, Pipeline Expansion Remains CentralMay 15, 2025 | finance.yahoo.comMubadala Investment Co PJSC Invests $2.39 Million in United Therapeutics Co. (NASDAQ:UTHR)Mubadala Investment Co PJSC acquired a new position in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 6,763 shares of the biotechnology company's stock, valued at approximatMay 15, 2025 | marketbeat.comJanus Henderson Group PLC Raises Stock Position in United Therapeutics Co. (NASDAQ:UTHR)Janus Henderson Group PLC lifted its stake in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 1.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 468,996 shares of the biotechnology company's stock after buyinMay 15, 2025 | marketbeat.comDeutsche Bank AG Purchases 14,132 Shares of United Therapeutics Co. (NASDAQ:UTHR)Deutsche Bank AG boosted its position in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 10.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 143,629 shares of the biotechnology company's stock after acquiring an addiMay 15, 2025 | marketbeat.comBank of America Corp DE Boosts Stake in United Therapeutics Co. (NASDAQ:UTHR)Bank of America Corp DE grew its stake in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 6.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 179,077 shares of the biotechnology company'sMay 15, 2025 | marketbeat.comQ1 Therapeutics Earnings: United Therapeutics (NASDAQ:UTHR) ImpressesMay 14, 2025 | finance.yahoo.comInvestment Management Corp of Ontario Has $10.55 Million Position in United Therapeutics Co. (NASDAQ:UTHR)Investment Management Corp of Ontario increased its position in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 157.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 29,904 shares of the biotechMay 13, 2025 | marketbeat.comHudson Bay Capital Management LP Acquires 34,810 Shares of United Therapeutics Co. (NASDAQ:UTHR)Hudson Bay Capital Management LP raised its holdings in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 98.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 70,319 shares of the biotechnology company's stock afMay 13, 2025 | marketbeat.comDZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main Has $1.96 Million Holdings in United Therapeutics Co. (NASDAQ:UTHR)DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main decreased its position in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 56.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,541 shares ofMay 13, 2025 | marketbeat.comBNP Paribas Financial Markets Raises Stock Position in United Therapeutics Co. (NASDAQ:UTHR)BNP Paribas Financial Markets increased its position in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 5.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 36,114 shares of the biotechnology company's stockMay 13, 2025 | marketbeat.comLiquidia Corporation Provides Update on Litigation Filed by United Therapeutics | LQDA Stock NewsMay 12, 2025 | gurufocus.comLiquidia (LQDA) Faces Patent Infringement Lawsuit from United Therapeutics | LQDA Stock NewsMay 12, 2025 | gurufocus.comLiquidia Faces Patent Infringement Lawsuit by United TherapeuticsMay 12, 2025 | tipranks.comUnited Therapeutics Co. (NASDAQ:UTHR) Holdings Raised by Gotham Asset Management LLCGotham Asset Management LLC increased its stake in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 17.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 61,179 shares of the biotechnology companMay 12, 2025 | marketbeat.com Get United Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for UTHR and its competitors with MarketBeat's FREE daily newsletter. Email Address UTHR Media Mentions By Week UTHR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. UTHR News Sentiment▼1.020.87▲Average Medical News Sentiment UTHR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. UTHR Articles This Week▼2314▲UTHR Articles Average Week Get United Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for UTHR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ALNY News BIIB News INCY News NBIX News EXEL News BMRN News EXAS News HALO News RGEN News MDGL News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:UTHR) was last updated on 5/31/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding United Therapeutics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share United Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy UTHR Stock Free UTHR Stock Alerts